In a study of rectal cancer, BIK was also identified as a poor prognostic marker for microsatellite-stabilized colorectal cancer harboring KRAS mutations, and rectal cancer patients with high expression of BIK tended to have shorter survival times (Liu P. et al., 2022). The gene discussed is BIK; the disease is rectal cancer.